PRO-DEX INC (PDEX) Fundamental Analysis & Valuation

NASDAQ:PDEX • US74265M2052

Current stock price

53.4 USD
+0.8 (+1.52%)
Last:

This PDEX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. PDEX Profitability Analysis

1.1 Basic Checks

  • In the past year PDEX was profitable.
  • In the past year PDEX had a positive cash flow from operations.
  • PDEX had positive earnings in each of the past 5 years.
  • In multiple years PDEX reported negative operating cash flow during the last 5 years.
PDEX Yearly Net Income VS EBIT VS OCF VS FCFPDEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M

1.2 Ratios

  • PDEX has a better Return On Assets (18.21%) than 97.34% of its industry peers.
  • With an excellent Return On Equity value of 27.24%, PDEX belongs to the best of the industry, outperforming 96.28% of the companies in the same industry.
  • PDEX has a better Return On Invested Capital (17.60%) than 95.21% of its industry peers.
  • PDEX had an Average Return On Invested Capital over the past 3 years of 14.16%. This is significantly above the industry average of 9.15%.
  • The 3 year average ROIC (14.16%) for PDEX is below the current ROIC(17.60%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 18.21%
ROE 27.24%
ROIC 17.6%
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
PDEX Yearly ROA, ROE, ROICPDEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • PDEX's Profit Margin of 15.73% is amongst the best of the industry. PDEX outperforms 91.49% of its industry peers.
  • In the last couple of years the Profit Margin of PDEX has declined.
  • PDEX's Operating Margin of 15.74% is amongst the best of the industry. PDEX outperforms 85.11% of its industry peers.
  • PDEX's Operating Margin has declined in the last couple of years.
  • PDEX has a worse Gross Margin (28.29%) than 75.53% of its industry peers.
  • PDEX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 15.74%
PM (TTM) 15.73%
GM 28.29%
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
PDEX Yearly Profit, Operating, Gross MarginsPDEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. PDEX Health Analysis

2.1 Basic Checks

  • PDEX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for PDEX has been reduced compared to 1 year ago.
  • The number of shares outstanding for PDEX has been reduced compared to 5 years ago.
  • The debt/assets ratio for PDEX is higher compared to a year ago.
PDEX Yearly Shares OutstandingPDEX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M
PDEX Yearly Total Debt VS Total AssetsPDEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • PDEX has an Altman-Z score of 8.32. This indicates that PDEX is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 8.32, PDEX belongs to the best of the industry, outperforming 84.04% of the companies in the same industry.
  • PDEX has a debt to FCF ratio of 1.74. This is a very positive value and a sign of high solvency as it would only need 1.74 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 1.74, PDEX belongs to the best of the industry, outperforming 87.23% of the companies in the same industry.
  • A Debt/Equity ratio of 0.19 indicates that PDEX is not too dependend on debt financing.
  • PDEX has a Debt to Equity ratio (0.19) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.74
Altman-Z 8.32
ROIC/WACC2.05
WACC8.59%
PDEX Yearly LT Debt VS Equity VS FCFPDEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M

2.3 Liquidity

  • PDEX has a Current Ratio of 4.03. This indicates that PDEX is financially healthy and has no problem in meeting its short term obligations.
  • PDEX has a better Current ratio (4.03) than 64.36% of its industry peers.
  • PDEX has a Quick Ratio of 2.25. This indicates that PDEX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.25, PDEX is in line with its industry, outperforming 54.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.03
Quick Ratio 2.25
PDEX Yearly Current Assets VS Current LiabilitesPDEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. PDEX Growth Analysis

3.1 Past

  • PDEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.19%, which is quite impressive.
  • Measured over the past years, PDEX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.96% on average per year.
  • The Revenue has grown by 18.19% in the past year. This is quite good.
  • The Revenue has been growing by 13.84% on average over the past years. This is quite good.
EPS 1Y (TTM)61.19%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%8.2%
Revenue 1Y (TTM)18.19%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%11.12%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PDEX Yearly Revenue VS EstimatesPDEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
PDEX Yearly EPS VS EstimatesPDEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

5

4. PDEX Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 16.48, PDEX is valued correctly.
  • Based on the Price/Earnings ratio, PDEX is valued cheaply inside the industry as 85.64% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.87, PDEX is valued a bit cheaper.
  • A Price/Forward Earnings ratio of 22.00 indicates a rather expensive valuation of PDEX.
  • Based on the Price/Forward Earnings ratio, PDEX is valued a bit cheaper than 77.66% of the companies in the same industry.
  • PDEX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 38.51, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.48
Fwd PE 22
PDEX Price Earnings VS Forward Price EarningsPDEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PDEX indicates a rather cheap valuation: PDEX is cheaper than 82.98% of the companies listed in the same industry.
  • PDEX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. PDEX is cheaper than 78.72% of the companies in the same industry.
Industry RankSector Rank
P/FCF 28.46
EV/EBITDA 13.46
PDEX Per share dataPDEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The decent profitability rating of PDEX may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.5
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PDEX Dividend Analysis

5.1 Amount

  • No dividends for PDEX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PDEX Fundamentals: All Metrics, Ratios and Statistics

PRO-DEX INC

NASDAQ:PDEX (4/17/2026, 8:00:00 PM)

53.4

+0.8 (+1.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-29
Earnings (Next)04-30
Inst Owners32.12%
Inst Owner Change0%
Ins Owners36.66%
Ins Owner Change1.68%
Market Cap171.41M
Revenue(TTM)72.10M
Net Income(TTM)11.34M
Analysts82.86
Price Target57.12 (6.97%)
Short Float %11.81%
Short Ratio8.96
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)92.09%
Min EPS beat(2)9.67%
Max EPS beat(2)174.51%
EPS beat(4)3
Avg EPS beat(4)57.58%
Min EPS beat(4)-24.91%
Max EPS beat(4)174.51%
EPS beat(8)6
Avg EPS beat(8)52.92%
EPS beat(12)8
Avg EPS beat(12)22.58%
EPS beat(16)9
Avg EPS beat(16)17.56%
Revenue beat(2)2
Avg Revenue beat(2)12.24%
Min Revenue beat(2)5.75%
Max Revenue beat(2)18.74%
Revenue beat(4)2
Avg Revenue beat(4)4.19%
Min Revenue beat(4)-4.18%
Max Revenue beat(4)18.74%
Revenue beat(8)6
Avg Revenue beat(8)12.73%
Revenue beat(12)9
Avg Revenue beat(12)11.27%
Revenue beat(16)12
Avg Revenue beat(16)10.55%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 16.48
Fwd PE 22
P/S 2.38
P/FCF 28.46
P/OCF 26.52
P/B 4.12
P/tB 4.12
EV/EBITDA 13.46
EPS(TTM)3.24
EY6.07%
EPS(NY)2.43
Fwd EY4.55%
FCF(TTM)1.88
FCFY3.51%
OCF(TTM)2.01
OCFY3.77%
SpS22.46
BVpS12.97
TBVpS12.97
PEG (NY)N/A
PEG (5Y)1.5
Graham Number30.7482 (-42.42%)
Profitability
Industry RankSector Rank
ROA 18.21%
ROE 27.24%
ROCE 22.68%
ROIC 17.6%
ROICexc 21.36%
ROICexgc 21.37%
OM 15.74%
PM (TTM) 15.73%
GM 28.29%
FCFM 8.35%
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
ROICexc(3y)16.6%
ROICexc(5y)14.6%
ROICexgc(3y)16.62%
ROICexgc(5y)14.63%
ROCE(3y)18.25%
ROCE(5y)16.34%
ROICexgc growth 3Y23.73%
ROICexgc growth 5Y-8.41%
ROICexc growth 3Y23.84%
ROICexc growth 5Y-8.25%
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
F-Score7
Asset Turnover1.16
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.74
Debt/EBITDA 0.64
Cap/Depr 35.31%
Cap/Sales 0.61%
Interest Coverage 13.47
Cash Conversion 51.29%
Profit Quality 53.11%
Current Ratio 4.03
Quick Ratio 2.25
Altman-Z 8.32
F-Score7
WACC8.59%
ROIC/WACC2.05
Cap/Depr(3y)99.37%
Cap/Depr(5y)344.26%
Cap/Sales(3y)1.93%
Cap/Sales(5y)6.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.19%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%8.2%
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.19%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%11.12%
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.59%
EBIT growth 3Y27.48%
EBIT growth 5Y8.65%
EBIT Next Year10.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y99.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y59.11%
OCF growth 3YN/A
OCF growth 5YN/A

PRO-DEX INC / PDEX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for PRO-DEX INC?

ChartMill assigns a fundamental rating of 6 / 10 to PDEX.


What is the valuation status for PDEX stock?

ChartMill assigns a valuation rating of 5 / 10 to PRO-DEX INC (PDEX). This can be considered as Fairly Valued.


What is the profitability of PDEX stock?

PRO-DEX INC (PDEX) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for PDEX stock?

The Price/Earnings (PE) ratio for PRO-DEX INC (PDEX) is 16.48 and the Price/Book (PB) ratio is 4.12.


What is the earnings growth outlook for PRO-DEX INC?

The Earnings per Share (EPS) of PRO-DEX INC (PDEX) is expected to decline by -4.43% in the next year.